Terms ending in 2031
Every in-force patent on Eagle Pharmaceuticals, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,609,707 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,000,021 | Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,034,908 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,144,568 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,265,831 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,572,796 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,572,797 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,572,887 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,572,888 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,579,384 | Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | |
| 13 more term ends in 2031 · Pro | |||||
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.